BCM
AGN

Bluefin Capital Management’s Allergan plc AGN Stock Holding History

Bluefin Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,000
Closed -$324K – 534
2020
Q1 		$324K Buy
+50,000
New +$9.41M 0.04% 210
2019
Q3 		– Sell
-85,000
Closed -$2.78M – 588
2019
Q2 		$2.78M Buy
+85,000
New +$11.8M 0.39% 44
2018
Q1 		– Sell
-402,200
Closed -$21K – 632
2017
Q4 		$21K Buy
402,200
+216,700
+117% +$38.9M ﹤0.01% 418
2017
Q3 		$1.27M Sell
185,500
-34,900
-16% -$8.12M 0.15% 124
2017
Q2 		$6.88M Buy
220,400
+31,800
+17% +$7.47M 0.74% 23
2017
Q1 		$6.45M Sell
188,600
-1,012,900
-84% -$236M 0.84% 22
2016
Q4 		$2.63M Buy
1,201,500
+230,500
+24% +$47.7M 0.16% 74
2016
Q3 		$4.15M Buy
+971,000
New +$237M 0.15% 38

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bluefin Capital Management's AGN Position: Q2 2020 in Review

Bluefin Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 38,645 shares — an estimated $6.84M sold.

Bluefin Capital Management first reported a position in AGN in Q4 2013 and held it in 11 quarters. The position peaked at $103M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bluefin Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 38,645 Allergan plc shares in Q2 2020, an estimated $6.84M.
  • Bluefin Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 11 quarters.
  • Bluefin Capital Management's Allergan plc position peaked at $103M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bluefin Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.